Hope – AMD is an eye disease in which part of the retina deteriorates
This is an important hope for the nearly 300,000 people with Parkinson’s disease in France. A drug could delay one of the forms of age-related macular degeneration (AMD), the leading cause of visual impairment in people over 50, according to a study published by Inserm.
AMD is an eye disease corresponding to a degradation of a part of the retina (the macula). If the peripheral part remains intact, this pathology is nonetheless very disabling because it can lead to the loss of central vision.
Avoid injections into the eye
Two forms of the disease have a roughly equivalent prevalence: the neovascular form, called “exudative” or “wet”, and the atrophic or “advanced dry” form. While the dry form currently has no treatment, the neovascular form can be slowed down by regular injections into the eye. But given the severity of the treatment, alternatives are desirable.
Epidemiological studies have already highlighted a possible association between Parkinson’s disease and a reduced risk of neovascular AMD. In a new study, published this summer in the journal “The journal of clinical investigation”, researchers from Inserm, CNRS, and Sorbonne University at the(…) - 20minutes
Also read:
Parkinson’s disease: What are the symptoms that should alert you?
This teenager has an implant in his skull that reduces his epileptic seizures, a world first
Alzheimer’s: The drug agency suspends a preventive treatment by patch, resulting from wild clinical trials
Antidiabetic Tested as Parkinson’s Treatment Shows Encouraging First Results
Related News :